Logo image of 0Q3.DE

BEYOND MEAT INC (0Q3.DE) Stock Fundamental Analysis

FRA:0Q3 - Deutsche Boerse Ag - US08862E1091 - Common Stock - Currency: EUR

2.813  -0.08 (-2.73%)

Fundamental Rating

2

0Q3 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 56 industry peers in the Food Products industry. 0Q3 may be in some trouble as it scores bad on both profitability and health. 0Q3 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year 0Q3 has reported negative net income.
0Q3 had a negative operating cash flow in the past year.
0Q3 had negative earnings in each of the past 5 years.
In the past 5 years 0Q3 always reported negative operating cash flow.
0Q3.DE Yearly Net Income VS EBIT VS OCF VS FCF0Q3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of 0Q3 (-24.67%) is worse than 87.50% of its industry peers.
Industry RankSector Rank
ROA -24.67%
ROE N/A
ROIC N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
0Q3.DE Yearly ROA, ROE, ROIC0Q3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

0Q3 has a Gross Margin of 11.57%. This is amonst the worse of the industry: 0Q3 underperforms 89.29% of its industry peers.
In the last couple of years the Gross Margin of 0Q3 has declined.
The Profit Margin and Operating Margin are not available for 0Q3 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
0Q3.DE Yearly Profit, Operating, Gross Margins0Q3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

0Q3 does not have a ROIC to compare to the WACC, probably because it is not profitable.
0Q3 has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 0Q3 has been increased compared to 5 years ago.
Compared to 1 year ago, 0Q3 has a worse debt to assets ratio.
0Q3.DE Yearly Shares Outstanding0Q3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
0Q3.DE Yearly Total Debt VS Total Assets0Q3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -2.68, we must say that 0Q3 is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of 0Q3 (-2.68) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.68
ROIC/WACCN/A
WACC5.68%
0Q3.DE Yearly LT Debt VS Equity VS FCF0Q3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

0Q3 has a Current Ratio of 3.39. This indicates that 0Q3 is financially healthy and has no problem in meeting its short term obligations.
0Q3 has a Current ratio of 3.39. This is amongst the best in the industry. 0Q3 outperforms 89.29% of its industry peers.
A Quick Ratio of 2.07 indicates that 0Q3 has no problem at all paying its short term obligations.
0Q3's Quick ratio of 2.07 is amongst the best of the industry. 0Q3 outperforms 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 2.07
0Q3.DE Yearly Current Assets VS Current Liabilites0Q3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.52% over the past year.
Looking at the last year, 0Q3 shows a decrease in Revenue. The Revenue has decreased by -2.17% in the last year.
0Q3 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.85% yearly.
EPS 1Y (TTM)36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.94%
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-9.09%

3.2 Future

The Earnings Per Share is expected to grow by 15.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.52% on average over the next years.
EPS Next Y26.15%
EPS Next 2Y19.23%
EPS Next 3Y17.56%
EPS Next 5Y15.49%
Revenue Next Year-4.6%
Revenue Next 2Y0.18%
Revenue Next 3Y-0.32%
Revenue Next 5Y2.52%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
0Q3.DE Yearly Revenue VS Estimates0Q3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
0Q3.DE Yearly EPS VS Estimates0Q3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 0Q3. In the last year negative earnings were reported.
Also next year 0Q3 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
0Q3.DE Price Earnings VS Forward Price Earnings0Q3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
0Q3.DE Per share data0Q3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as 0Q3's earnings are expected to grow with 17.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.23%
EPS Next 3Y17.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 0Q3!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND MEAT INC

FRA:0Q3 (6/4/2025, 7:00:00 PM)

2.813

-0.08 (-2.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners44.34%
Inst Owner ChangeN/A
Ins Owners4.58%
Ins Owner ChangeN/A
Market Cap215.11M
Analysts47.5
Price Target3.29 (16.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.27%
Min EPS beat(2)-46.83%
Max EPS beat(2)-35.72%
EPS beat(4)1
Avg EPS beat(4)-18.93%
Min EPS beat(4)-46.83%
Max EPS beat(4)9.47%
EPS beat(8)2
Avg EPS beat(8)-12.35%
EPS beat(12)4
Avg EPS beat(12)-11.65%
EPS beat(16)4
Avg EPS beat(16)-26.24%
Revenue beat(2)0
Avg Revenue beat(2)-5.58%
Min Revenue beat(2)-10.16%
Max Revenue beat(2)-1%
Revenue beat(4)1
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-10.16%
Max Revenue beat(4)4.04%
Revenue beat(8)2
Avg Revenue beat(8)-2.87%
Revenue beat(12)3
Avg Revenue beat(12)-3.4%
Revenue beat(16)4
Avg Revenue beat(16)-3.01%
PT rev (1m)0.1%
PT rev (3m)-34.61%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)-22.27%
EPS NY rev (1m)-8.25%
EPS NY rev (3m)-9.17%
Revenue NQ rev (1m)-12.26%
Revenue NQ rev (3m)-14.16%
Revenue NY rev (1m)-5.38%
Revenue NY rev (3m)-7.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.99
EYN/A
EPS(NY)-1.17
Fwd EYN/A
FCF(TTM)-1.23
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS3.67
BVpS-7.46
TBVpS-7.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.57%
FCFM N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.69%
Cap/Sales 4.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.39
Quick Ratio 2.07
Altman-Z -2.68
F-Score4
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)98.2%
Cap/Depr(5y)297.95%
Cap/Sales(3y)7.98%
Cap/Sales(5y)14.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.94%
EPS Next Y26.15%
EPS Next 2Y19.23%
EPS Next 3Y17.56%
EPS Next 5Y15.49%
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-9.09%
Revenue Next Year-4.6%
Revenue Next 2Y0.18%
Revenue Next 3Y-0.32%
Revenue Next 5Y2.52%
EBIT growth 1Y52.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.28%
EBIT Next 3Y19.88%
EBIT Next 5Y19.67%
FCF growth 1Y57.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.76%
OCF growth 3YN/A
OCF growth 5YN/A